← All organizations

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Academic/Hospital

Also known as: Ariel Dogliotti | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | Instituto Milstein-CONICET

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2017

Last known activity

Feb 6, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 6 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Indications

Recent trials (17)

  • NCT05752201OfficialPhase 2/Phase 3Feb 6, 2023
  • NCT05752201Lead sponsorPhase 2/Phase 3Feb 6, 2023
  • NCT05752201Overall official - principal investigatorPhase 2/Phase 3Feb 6, 2023
  • NCT05752201Reponsible party - principal investigatorPhase 2/Phase 3Feb 6, 2023
  • NCT05752201Sponsor investigatorPhase 2/Phase 3Feb 6, 2023
  • NCT04521322Lead sponsorPhase 4Jul 24, 2020
  • NCT04521322CollaboratorPhase 4Jul 24, 2020
  • NCT04521322Sponsor investigatorPhase 4Jul 24, 2020
  • NCT04521322Study directorPhase 4Jul 24, 2020
  • NCT04395105Reponsible party - principal investigatorPhase 3May 18, 2020
  • NCT04395105Overall official - principal investigatorPhase 3May 18, 2020
  • NCT04395105Lead sponsorPhase 3May 18, 2020
  • NCT04383535Overall official - principal investigatorN/AMay 15, 2020
  • NCT04535063Lead sponsorPhase 3Apr 18, 2020
  • NCT04535063Reponsible party - principal investigatorPhase 3Apr 18, 2020

Details

Last known activity
Feb 6, 2023